本文へ移動
cccskills
無料GitHub で公開

es-pump-supplies-availability

Verify that insulin pump supplies (provided by patient or family) will be available throughout the hospitalization to support continued pump use. Triggered by questions such as "Do we have sufficient pump supplies for the hospital stay?"

インストール方法を見る

含まれるファイル(1)

  • SKILL.md2.2 KB

SKILL.md(原文)

インストールする前に、エージェントに与えられる指示の中身を確認できます。

Confirm availability of insulin pump supplies for hospitalization duration

STEP 1 — Gather Information

Determine expected hospitalization duration and inventory of pump supplies (infusion sets, reservoirs, batteries, adhesives, alcohol wipes) available from patient or family.

STEP 2 — Rule In / Rule Out

Are pump supplies sufficient to cover the entire hospitalization? If YES → proceed to assess patient ability and contraindications. If NO → arrange for additional supplies or plan transition to subcutaneous insulin therapy.

STEP 3 — Classify or Stratify

Assess patient ability to self-manage pump (consciousness, dexterity, understanding) and check for contraindications (ICU stay, DKA/HHS, inability to adjust settings). If patient can safely self-manage and no contraindications → proceed to decide. If not → transition to subcutaneous insulin therapy.

STEP 4 — Decide

If supplies sufficient and patient able to self-manage with no contraindications → continue insulin pump therapy during hospitalization. Otherwise → transition to scheduled subcutaneous basal bolus insulin therapy before discontinuation of pump.

Clinical Guardrails / Mimics / Pitfalls

Do not continue pump if patient lacks ability to adjust settings, is in ICU, has DKA/HHS, or if supplies will run out; do not assume hospital will provide pump supplies; do not ignore need for basal rate adaptation at admission.

Concrete Clinical Example

A 58-year-old with type 1 diabetes on pump admitted for elective surgery expected stay 3 days. Patient brings 2 infusion sets, 3 reservoirs, batteries. Hospital has pump-expert nurse. Supplies sufficient for 3 days, patient alert and able to manage pump, no contraindications → continue pump.

Source: Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2022, https://doi.org/10.1210/clinem/dgac278

レビュー

まだレビューはありません。使ってみた感想をお寄せください。

同じリポジトリのスキル

概要と使いどころ

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL122026年10月5日 更新

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL122026年10月5日 更新

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL122026年10月5日 更新

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL122026年10月5日 更新

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL122026年10月5日 更新

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL122026年10月5日 更新

dromlakhani のスキルをすべて見る

このスキルの問題を報告する